Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B5586 ADX 10059 hydrochlorideSummary: Negative allosteric modulator at mGlu5
- B5591 SR 16584Summary: α3β4 nAChR antagonist
- B5595 MFZ 10-7Summary: negative allosteric modulator of the mGlu5 receptor
- B5597 SEN 12333Summary: α7 nicotinic acetylcholine receptor (nAChR) agonist
- B5615 A 844606Summary: α7 nAChR partial agonist
- B5624 STF 083010Target: Inositol-requiring enzyme 1 (IRE1)Summary: IRE1α endonuclease inhibitor
- B5632 PTAC oxalateSummary: muscarinic receptor ligand
- B5639 A 412997 dihydrochlorideSummary: Selective D4 agonist
- B5708 SIB 1553A hydrochlorideSummary: nicotinic acetylcholine receptor (nAChR) agonist
- B5709 VUF 10460Summary: histamine H4 receptor agonist